In the phase 3 CORALreef Lipids trial, the oral PCSK9 inhibitor enlicitide reduced LDL cholesterol by 57% at 24 weeks and also lowered non HDL cholesterol, apolipoprotein B, and lipoprotein(a). Adverse events were Liposomal Glutathione Antioxidant Complex, 15 oz (443 ml) Liposomal Glutathione Supplement 60 Vegetable Capsules Orthoplex Liposomal Glutathione Oral Powder 50g The Vitamins Shoppe Orthoplex Liposomal Glutathione 40g FemmeWell